Zura Bio (ZURA) News Today $1.28 -0.07 (-5.17%) As of 11:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Zura Bio (NASDAQ:ZURA) Releases Quarterly Earnings ResultsZura Bio (NASDAQ:ZURA - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.09. The company had revenue of $0.00 million during the quarter.March 28 at 10:38 AM | marketbeat.comZura Bio's (ZURA) Buy Rating Reaffirmed at GuggenheimGuggenheim reiterated a "buy" rating and set a $15.00 price objective on shares of Zura Bio in a report on Wednesday.March 27 at 9:46 AM | marketbeat.comZura Bio (NASDAQ:ZURA) Price Target Cut to $10.00 by Analysts at Chardan CapitalChardan Capital lowered their target price on Zura Bio from $12.00 to $10.00 and set a "buy" rating for the company in a report on Wednesday.March 27 at 8:26 AM | marketbeat.comGuggenheim Reiterates "Buy" Rating for Zura Bio (NASDAQ:ZURA)March 27 at 4:17 AM | americanbankingnews.comZura Bio (NASDAQ:ZURA) Given New $10.00 Price Target at Chardan CapitalMarch 27 at 3:37 AM | americanbankingnews.comHopeful Week For Insiders Who Bought US$1.01m Of Zura Bio StockMarch 26 at 2:16 PM | finance.yahoo.comZura Bio Limited: 2024 Financial Results and Strategic ProgressMarch 26 at 12:03 AM | tipranks.comZura Bio Reports Full Year 2024 Financial Results and Recent Corporate UpdatesMarch 25 at 7:01 AM | businesswire.comZura Bio (ZURA) Projected to Post Earnings on ThursdayMarch 25 at 1:44 AM | americanbankingnews.comZura Bio (ZURA) Projected to Post Quarterly Earnings on ThursdayZura Bio (NASDAQ:ZURA) will be releasing earnings before the market opens on Thursday, March 27, Financial Modeling Prep reports.March 20, 2025 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Given Consensus Rating of "Buy" by BrokeragesShares of Zura Bio Limited (NASDAQ:ZURA - Get Free Report) have received a consensus rating of "Buy" from the seven ratings firms that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating, five have issued a buy rating andMarch 10, 2025 | marketbeat.comZura Bio (NASDAQ:ZURA) Trading Down 1.6% - Here's WhyZura Bio (NASDAQ:ZURA) Trading Down 1.6% - Should You Sell?March 8, 2025 | marketbeat.comZura Bio to Present at the Leerink Partners Global Healthcare ConferenceFebruary 24, 2025 | businesswire.comZura Bio Limited (NASDAQ:ZURA) Receives Average Recommendation of "Buy" from AnalystsShares of Zura Bio Limited (NASDAQ:ZURA - Get Free Report) have been assigned a consensus recommendation of "Buy" from the seven research firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, five haveFebruary 13, 2025 | marketbeat.comZURA stock touches 52-week low at $1.44 amid market shiftsFebruary 11, 2025 | msn.comCantor Fitzgerald Forecasts Zura Bio FY2025 EarningsZura Bio Limited (NASDAQ:ZURA - Free Report) - Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Zura Bio in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst J. Schimmer anticipates that the company will post earnings per shareJanuary 23, 2025 | marketbeat.comWe Think Zura Bio (NASDAQ:ZURA) Can Afford To Drive Business GrowthJanuary 22, 2025 | finance.yahoo.comZura Bio Limited (NASDAQ:ZURA) Given Consensus Recommendation of "Buy" by BrokeragesShares of Zura Bio Limited (NASDAQ:ZURA - Get Free Report) have been given a consensus rating of "Buy" by the seven brokerages that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating, five have assigned a buy rating and oneJanuary 19, 2025 | marketbeat.comZura Bio Highlights Strategic Goals and Clinical AdvancesJanuary 13, 2025 | tipranks.comGeode Capital Management LLC Acquires 377,545 Shares of Zura Bio Limited (NASDAQ:ZURA)Geode Capital Management LLC boosted its holdings in Zura Bio Limited (NASDAQ:ZURA - Free Report) by 70.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 912,625 shares of the company's stock after buyingJanuary 7, 2025 | marketbeat.comZura Bio initiates Phase II systemic sclerosis treatment trialDecember 25, 2024 | msn.comZura Bio (NASDAQ:ZURA) Receives Neutral Rating from HC WainwrightHC Wainwright restated a "neutral" rating and set a $5.00 price objective on shares of Zura Bio in a report on Tuesday.December 24, 2024 | marketbeat.comLeerink Partnrs Forecasts Stronger Earnings for Zura BioZura Bio Limited (NASDAQ:ZURA - Free Report) - Equities researchers at Leerink Partnrs lifted their FY2025 earnings per share (EPS) estimates for shares of Zura Bio in a research note issued on Wednesday, December 11th. Leerink Partnrs analyst F. Khurshid now anticipates that the company will posDecember 13, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Receives Average Rating of "Buy" from BrokeragesShares of Zura Bio Limited (NASDAQ:ZURA - Get Free Report) have been given an average recommendation of "Buy" by the seven analysts that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation, five have issued a buy recommendationNovember 30, 2024 | marketbeat.comBraidwell LP Buys New Position in Zura Bio Limited (NASDAQ:ZURA)Braidwell LP bought a new stake in Zura Bio Limited (NASDAQ:ZURA - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 2,472,806 shares of the company's stock, valued at approximately $10,040,000. Braidwell LP owned approximately 3.68% of Zura BioNovember 29, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Director Sells $2,734,458.09 in StockNovember 28, 2024 | insidertrades.comZura Bio Limited (NASDAQ:ZURA) Short Interest UpdateZura Bio Limited (NASDAQ:ZURA - Get Free Report) saw a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 4,960,000 shares, a growth of 183.4% from the October 31st total of 1,750,000 shares. Currently, 10.6% of the shares of the company are sold short. Based on an average trading volume of 444,500 shares, the short-interest ratio is currently 11.2 days.November 28, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) is Great Point Partners LLC's 10th Largest PositionGreat Point Partners LLC trimmed its position in Zura Bio Limited (NASDAQ:ZURA - Free Report) by 29.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,263,672 shares of the company's stock after selling 1November 27, 2024 | marketbeat.comZura Bio to Present at the Piper Sandler 36th Annual Healthcare ConferenceNovember 25, 2024 | businesswire.comHC Wainwright Reaffirms "Neutral" Rating for Zura Bio (NASDAQ:ZURA)HC Wainwright reissued a "neutral" rating and set a $5.00 target price on shares of Zura Bio in a report on Monday.November 18, 2024 | marketbeat.comZura Bio submits protocol to FDA for Phase 2 study of TibulizumabNovember 15, 2024 | markets.businessinsider.comZura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic SclerosisNovember 14, 2024 | businesswire.comQ3 Earnings Forecast for Zura Bio Issued By HC WainwrightZura Bio Limited (NASDAQ:ZURA - Free Report) - Research analysts at HC Wainwright raised their Q3 2025 earnings per share estimates for Zura Bio in a report released on Monday, November 11th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings of ($0.23) per shareNovember 13, 2024 | marketbeat.comZura Bio's (ZURA) Neutral Rating Reaffirmed at HC WainwrightHC Wainwright restated a "neutral" rating and set a $5.00 target price on shares of Zura Bio in a research note on Monday.November 11, 2024 | marketbeat.comChardan Capital Has Lowered Expectations for Zura Bio (NASDAQ:ZURA) Stock PriceChardan Capital reduced their price target on Zura Bio from $14.00 to $12.00 and set a "buy" rating for the company in a research report on Friday.November 11, 2024 | marketbeat.comZura Bio Limited: Q3 2024 Financial Insights and Strategic ProgressNovember 8, 2024 | markets.businessinsider.comZura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate UpdatesNovember 7, 2024 | businesswire.comQ3 Earnings Forecast for Zura Bio Issued By Leerink PartnrsZura Bio Limited (NASDAQ:ZURA - Free Report) - Analysts at Leerink Partnrs issued their Q3 2024 earnings per share estimates for shares of Zura Bio in a report released on Monday, November 4th. Leerink Partnrs analyst F. Khurshid anticipates that the company will earn ($0.14) per share for the quNovember 6, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Receives Average Rating of "Moderate Buy" from BrokeragesZura Bio Limited (NASDAQ:ZURA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the five analysts that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on theNovember 5, 2024 | marketbeat.comZura Bio (NASDAQ:ZURA) Rating Increased to Strong-Buy at Leerink PartnrsLeerink Partnrs raised Zura Bio to a "strong-buy" rating in a report on Monday.November 5, 2024 | marketbeat.comZura Bio initiated with an Outperform at LeerinkNovember 5, 2024 | markets.businessinsider.comLeerink Partners Initiates Coverage of Zura Bio (ZURA) with Outperform RecommendationNovember 5, 2024 | msn.comZura Bio’s Strategic Positioning and Promising Asset Portfolio: A Buy Recommendation by Analyst Faisal KhurshidNovember 5, 2024 | markets.businessinsider.comLeerink Partners Begins Coverage on Zura Bio (NASDAQ:ZURA)Leerink Partners began coverage on shares of Zura Bio in a research report on Monday. They set an "outperform" rating and a $15.00 price target on the stock.November 4, 2024 | marketbeat.comZura Bio to Participate in Two Upcoming Investor Conferences in NovemberOctober 30, 2024 | businesswire.comZura Bio (NASDAQ:ZURA) Stock, Short Interest ReportOctober 29, 2024 | benzinga.comZura Bio (NASDAQ:ZURA) Stock Quotes, Forecast and News SummaryOctober 29, 2024 | benzinga.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Universal Health (UHS), Apellis Pharmaceuticals (APLS) and Zura Bio (ZURA)October 29, 2024 | markets.businessinsider.comZura Bio’s Leadership Instability and Uncertain Prospects Lead to Hold RatingOctober 23, 2024 | markets.businessinsider.comZura Bio's (ZURA) "Neutral" Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "neutral" rating and issued a $5.00 target price on shares of Zura Bio in a research note on Monday.October 21, 2024 | marketbeat.com Remove Ads Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address ZURA Media Mentions By Week ZURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZURA News Sentiment▼0.280.78▲Average Medical News Sentiment ZURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZURA Articles This Week▼162▲ZURA Articles Average Week Remove Ads Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AURA News ESPR News TKNO News TSHA News BNTC News AMLX News ATYR News CMPX News AQST News TECX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZURA) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersCould This $6.9 Trillion Cash Wave “Reboot” Wall Street?Move Your Money Before April 2, 2025 Trump is about to make some big announcements on April 2. And they cou...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zura Bio Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zura Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ZURA Stock Free ZURA Stock Alerts